INTS
Intensity Therapeutics, Inc. Common stock
stockNASDAQ
At CloseOct 2, 2026 3:48:51 PM EDT
3.44USD+7.165%(+0.23)15,440
Loading…
Loading…
11.13M
Healthcare
Biotechnology
HQ
Westport, CT, USA
Previous Close
$3.21
Beta
-1.49
52-Week High
$43.50 2025-10-30
52-Week Low
$3.21 2026-10-01
SMA 50
$4.12
SMA 200
$5.91
Avg. Vol 10D
16,677
Avg. Vol 30D
24,502
Avg. Vol 90D
36,451
Relative Vol
0.63
3.26M
1.46M
44.60%
31,298
2.15%
2.60
42%/58%
87.49%
84.33%
6.0600%
200,000
825
2,749
9,372
Nov 5, 2026 (31d)
Feb 19, 2026 · 1-for-25 (reverse)
INTS Profile
intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company's technology and products.
INTS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.65 | 2026-09-28 | -6.58% | 11.313 |
| 1M | 4.10 | 2026-09-04 | -16.83% | 0.877 |
| 3M | 4.52 | 2026-07-06 | -24.56% | -0.891 |
| 6M | 5.49 | 2026-04-06 | -37.89% | 0.449 |
| 1Y | 7.00 | 2025-10-03 | -51.29% | -1.487 |
| 2Y | 93.75 | 2024-10-04 | -96.36% | — |
| 5Y | 149.00 | 2023-06-30 | -97.71% | -0.228 |
INTS Stock Summary
Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) stock price today is $3.41, and today's volume is 15,440. INTS is up 6.231% today. The 30 day average volume is 24,502. INTS market cap is $11.13M with 3.26M shares outstanding.